(from the application): Alpha-MSH acts as a potent immunomodulator of cutaneous inflammation. This neuropeptide is produced in the skin and has been shown to mediate both immunostimulating and immunosuppressive activities. The general hypothesis to be tested in this application is that alpha-MSH may be an important modulator of dermal microvascular endothelial cell (DMEC) inflammatory responses such as chemokine production and cellular adhesion molecule expression which are critical initiating events in the cascade of cutaneous inflammation. It remains to be determined if alpha-MSH upregulates or suppresses DMEC mediated inflammation. The role of endothelial cells in alpha-MSH mediated cutaneous inflammation will be tested in the following specific aims which utilize both an in vitro and in vivo model system, employing cultured HDMEC and mice possessing either full wild type or attenuated response capabilities specific for the distinctive pathway of alpha-MSH initiated response under investigation.
Specific Aim #1 : To determine the effect of alpha-MSH on HDMEC chemokine production. Studies designed in this specific aim are designed to examine the ability of alpha-MSH to modulate the production of HDMEC C-X-C and C-C chemokines which may act as leukocyte chemotactic agents in inflammatory skin disease.
Specific Aim #2 : To determine the effect of alpha-MSH on HDMEC cellular adhesion molecule expression and leukocyte adhesion. Studies designed in this aim will test the ability of alpha-MSH to modulate the expression of HDMEC cellular adhesion molecules ICAM-1, VCAM-1, and E-selectin. In parallel, functional studies will be carried out measuring the effect of alpha-MSH on leukocyte adhesion to HDMEC.
Specific Aim #3 : To determine the effect of alpha-MSH in DMEC mediated responses in inflammatory skin disease. Studies designed to test this aim will address the contribution of alpha-MSH-dependent activation of DMEC in the pathogenesis of inflammation generated in three distinct murine models of common cutaneous inflammatory diseases: allergic contact dermatitis, irritant dermatitis, and acute photodermatitis in wild type and genetically altered animals. The results of these investigations will lead to a better understanding of the complex mechanisms involved in endothelial cell mediated inflammation of the skin and to improved treatment strategies for cutaneous inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Small Research Grants (R03)
Project #
5R03AR044969-03
Application #
6055665
Study Section
Special Emphasis Panel (ZAR1-TNL-A (O1))
Program Officer
Moshell, Alan N
Project Start
1997-09-30
Project End
2001-08-31
Budget Start
1999-09-01
Budget End
2001-08-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Emory University
Department
Dermatology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Scholzen, Thomas E; Steinhoff, Martin; Sindrilaru, Anca et al. (2004) Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J 18:1007-9
Scholzen, T E; Sunderkotter, C; Kalden, D-H et al. (2003) Alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 144:360-70
Scholzen, T E; Steinhoff, M; Bonaccorsi, P et al. (2001) Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol 166:1285-91
Burbach, G J; Kim, K H; Zivony, A S et al. (2001) The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 117:1075-82
Scholzen, T E; Kalden, D H; Brzoska, T et al. (2000) Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J Invest Dermatol 115:1021-8
Scholzen, T E; Brzoska, T; Kalden, D H et al. (1999) Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: mediators of photodermatitis and cutaneous inflammation. J Investig Dermatol Symp Proc 4:55-60
Scholzen, T; Armstrong, C A; Bunnett, N W et al. (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81-96